Compare KMDA & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | ECX |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.3M | 412.6M |
| IPO Year | 2013 | 2022 |
| Metric | KMDA | ECX |
|---|---|---|
| Price | $8.03 | $0.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $13.50 | $3.05 |
| AVG Volume (30 Days) | 126.6K | ★ 975.2K |
| Earning Date | 11-09-2026 | 11-02-2026 |
| Dividend Yield | ★ 5.05% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.50 | $29.03 |
| Revenue Next Year | $12.63 | $18.65 |
| P/E Ratio | $24.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.50 | $0.88 |
| 52 Week High | $9.35 | $2.70 |
| Indicator | KMDA | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 29.32 |
| Support Level | $7.91 | N/A |
| Resistance Level | $8.05 | $1.14 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 7.77 | 4.21 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China. The companies core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.